Using population health management approaches, ICHP is supporting primary care teams in North West London (NWL) to embed a lipid management pathway that enables early diagnosis and prevention. An important treatment option in this pathway for patients identified at risk of CVD, is Inclisiran – a novel anti-cholesterol drug approved by the National Institute for Health and Care Excellence (NICE) used for secondary prevention. In addition, to facilitate this pathway and appropriate management for patients on the lipid management pathway, ICHP has supported a pilot which enables multi-disciplinary team (MDT) working amongst primary and secondary care teams.
ICHP facilitated the set-up of a Clinician Working Group, which has provided NWL clinical leadership groups with assurance of safe introduction of this new pathway. This group comprises secondary care clinicians and the GP Co-Chair of the Integrated Care System CVD Executive Leadership Group. One clinician in this working group has also become the AHSN clinical champion for this lipid pathway approach. The development of clinician and patient resource packs has also helped us to deliver a clear, standardised approach across NWL. To help empower clinicians to tackle lipid management, we worked collaboratively across the local healthcare system to host webinars which provided a forum for conversation and questions from primary care staff.